rr&d center of excellence for the medical consequences of spinal cord injury william a. bauman,...
TRANSCRIPT
![Page 1: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/1.jpg)
RR&D Center of Excellencefor the
Medical Consequencesof Spinal Cord Injury
William A. Bauman, M.D.Director
Ann M. Spungen, Ed.DCo-Director
January 21, 2010Rancho Los Amigo National Rehabilitation Hospital
![Page 2: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/2.jpg)
Program Lines of Study
1. Endocrine ProgramWilliam A. Bauman, MD
2. Pulmonary ProgramGregory J. Schilero
3. Automomic Program Jill M. Wecht, EdD
4. Gastrointestinal Program Mark A. Korsten, MD
5. Molecular ProgramChristopher P. Cardozo, MD
![Page 3: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/3.jpg)
Anabolic Hormones
Disuse Osteoporosis
Carbohydrate Metabolism
Lipid Metabolism
Endocrine Program
Coronary Heart Disease
![Page 4: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/4.jpg)
Osteoporosis in SCI
• SCI is a nonweight bearing condition.
• Bone is lost rapidly with acute SCI.– goal is to preserve bone architecture & mass
• Bone continues to be lost years after SCI– goal is to replace bone mass
![Page 5: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/5.jpg)
Endocrine Program
Disuse Osteoporosis• Pharmacological intervention:
Acute SCI: pamidronate & zoledronate Chronic SCI: Hectoral (1-α-hydroxyvitamin D2)
• Low amplitude, high frequency mechanical stimulation
• Evaluation of DXA vs. other imaging modalities
• Vitamin D replacement therapy
![Page 6: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/6.jpg)
Bauman et al. Metabolism. 44:1612-1616, 1995.
• Absolute vitamin D deficiency state:32 of 100 (32%) in SCI 8 of 50 (16%) Cont
In Persons with SCI:
• Negative Correlation: PTH & 25 (OH) vitamin D levels
• Positive Correlation: PTH & 1,25 (OH)2 vitamin D levels
Calcium Metabolism in Chronic SCI
![Page 7: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/7.jpg)
Relationship between Serum PTH and Urinary NTx Levels
Ledger et al., J Clin Endocrinol Metab 80:3304-3310, 1995.
![Page 8: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/8.jpg)
Vitamin D Replacement: 2000 IU per Day for 3 Months
Baseline Month 1 Month 30
1
2
3
4
5
6
7
8Absolute Deficiency < 16 ng/mlRelative Deficiency < 30 ng/mlNo Deficiency ≥ 30 ng/ml
Nu
mb
er
of
Su
bje
cts
Bauman et al., Unpublished observation.
![Page 9: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/9.jpg)
Endocrine Program
Anabolic Hormones• Baclofen to increase IGF-1• Anabolic steroid agents• Testosterone replacement therapy
![Page 10: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/10.jpg)
Testosterone Replacement Therapy (TRT)
Intervention: 12 months of TRT
Endpoints: • Body composition• Muscle strength• Resting energy expenditure• Glucose tolerance• Autonomic function• Psychological assessment
![Page 11: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/11.jpg)
CountAge (yrs)
Height (cm)Weight (kg)BMI (kg/m2)
Duration of InjuryPara/TetraComplete/
Incomplete
TRT 6
43±5180±7
87.8±15.726.8±3.1
13±102/94/2
Control 9
37±9174±4
83.2±6.0
27.4±2.2
11±92/67/2
Characteristics of Subjects for theTestosterone Replacement Study
![Page 12: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/12.jpg)
Baseline Testosterone Washout
4042444648505254565860
TO
TA
L B
OD
Y LT
M (
kg
)
52.2
54.8 55.0
52.753.4
51.1
P<0.05
P<0.05
800900
10001100120013001400150016001700
REE (K
cal/
d)
1,386
Baseline Testosterone
1,508
1,341 1,349
P<0.05
122 Kcal/d
Testosterone Replacement Therapy
Design:TRT for 12 moWashout for 6 mo
Testosterone
Control
Bauman et al., Unpublished observation.
![Page 13: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/13.jpg)
Endocrine Program
Carbohydrate Metabolism• IV GTT• Oral GTT• Relationship to:
- Soft tissue (total & regional)
- Activity (V02max)
![Page 14: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/14.jpg)
Total Body Percent Lean Tissue & Age: Able-Bodied vs. SCI
Spungen et al., J Appl Physiol. 95:2398-2407, 2003.
TO
TAL
BO
DY
% L
EA
N
AGE (y)
25
35
45
55
65
75
85
95
10 20 30 40 50 60 70 80
SCI slope (-0.341, P<0.0001)
AB slope (-0.175, P<0.0001)
![Page 15: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/15.jpg)
Spungen et al., J Appl Physiol. 95:2398-2407, 2003.
Cross-Sectional Study: Chronic SCI
SCI
Control
0
5
10
15
20
25
30
35
40
< 40 y 40 y
Tota
l Bo
dy
Pe
rcen
t F
at
*
P<0.0001
*
* P<0.05 for Control vs. SCI
![Page 16: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/16.jpg)
Body Mass Index Criteria for Normal, Overweight and Obesity
Expert Panel on the Identification , Evaluation and Treatment of Overweight and Obesity in Adults. NIH NHLBI. 1998
UnderweightNormalOverweightObese
BMI (m/kg2)<18.5
18.5-24.925-29.9
>30
![Page 17: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/17.jpg)
Spungen et al., J Appl Physiol 95:2398-2407, 2003.
Tot
al B
ody%
Fat
Body Mass Index (kg/m2)
0
10
20
30
40
50
60
10 15 20 25 30 35 40 45
The Relationship of Percent Fat With Body Mass Index
SCIControl
![Page 18: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/18.jpg)
Ruderman NB, et al. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 34:1617-1621, 1981
Premise: Persons with metabolic disorders (type 2 DM, HTN, hypertriglyceridemia) who are not obese by standard weight tables or other readily available criteria, but who respond favorably to caloric restriction.
It is proposed that such individuals might be characterized by hyperinsulinism and an increase in fat cell size. Inactivity may be a contributing factor. As such, these individuals may benefit from exercise therapy.
![Page 19: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/19.jpg)
St-Onge MP, et al. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care. 27:2222-2228, 2004.
Prevalence rates MONW syndrome were determined in 7,602 adult participants of the Third National Health & Nutrition Examination Survey.
BMI 21-22.9 23-24.9
Men 4.13 5.35
Women 4.34 7.77
Odds ratios (OR) compared with those with BMI=18.5-20.9
![Page 20: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/20.jpg)
Effects of Spinal Cord Injury on the Determinants of Insulin Resistance
Muscle mass ↓Fat mass ↑
Activity ↓
![Page 21: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/21.jpg)
Oral Glucose Tolerance by Neurological Deficit
Complete Tetraplegia
Incomplete Tetraplegia
Complete Paraplegia
Incomplete ParaplegiaDM
IGT
NL
27%
50%
23%
56%24%
20%
69%
76%
17 %
14 %
6 %
18 %
Bauman et al., Spinal Cord. 37:765-771, 1999.
![Page 22: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/22.jpg)
Frequency of Impaired Glucose Tolerance and/orDiabetes Mellitus by Neurological Deficit
Neurological Subgroup
Complete Tetra
Incomplete Tetra
Complete Para
Incomplete Para
Percent
73*
44
24
31*p<0.0001
Bauman et al., Spinal Cord. 37:765-771, 1999.
![Page 23: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/23.jpg)
Frequency of Hyperinsulinemia
Group
Tetra
Para
Percent
53*
37*P<0.05
Bauman et al., Spinal Cord. 37:765-771, 1999.
![Page 24: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/24.jpg)
Ser
um
Glu
cose
(m
g/d
L)
0
25
50
75
100
125
150
175
200
225
250
0 30 60 90 120
NGT
IGT
DM
Time (minutes)
Serum Glucose Results from a 75 g OGTT in SCI
Bauman et al., Unpublished observation.
![Page 25: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/25.jpg)
Pla
sm
a In
sulin
(U
/ml)
0
20
40
60
80
100
120
140
160
180
0 30 60 90 120
NGT
IGT
DM
Time (minutes)
Plasma Insulin Results from a 75 g OGTT in SCI
Bauman et al., Unpublished observation.
![Page 26: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/26.jpg)
Percent of Subjects by SCI Group and FPI Category
0
5
10
15
20
25
30
35
40
0-5 5-9 10-14 15-19 20-100
TETRA
PARA
Per
cen
t
FPI CategoryBauman et al., Unpublished observation.
![Page 27: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/27.jpg)
Percent of Subjects by Group & 2-Hour Insulin Category
After a 75 g OGTT
0-49 50-99 100-150 > 1500
5
10
15
20
25
30
35
40
45 TETRA
PARA
Per
cen
t
Two-Hr Insulin CategoryBauman et al., Unpublished observation.
![Page 28: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/28.jpg)
Endocrine Program
Lipid Metabolism• Descriptive data• Relationship to body fat• Intervention with Niaspan
![Page 29: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/29.jpg)
Protective Effect of HDL Cholesterol
• Reverse cholesterol transport
• Anti-oxidant• Anti-inflammatory• Direct vascular• Anti-platelet• Anti-coagulant
![Page 30: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/30.jpg)
Bauman et al., Metab. 43:749-756, 1994.
Relationships between Insulin Sensitivity with VO2 max & HDL Cholesterol
![Page 31: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/31.jpg)
HDL as a Risk Factor in Persons with SCIDecreased plasma HDL cholesterol Elevated Total Cholesterol : HDL ratioHDL cholesterol < 40 mg/dL: 63%
HDL cholesterol < 35 mg/dL: 44%HDL cholesterol < 30 mg/dL: 19%
Bauman et al., Spinal Cord, 1998Bauman et al., Metabolism, 1994Bauman et al., Spinal Cord, 1999Bauman et al., Topics in Spinal Cord Injury Rehab, 2008
30
35
40
45
50
TetraComplete
TetraIncomplete
ParaComplete
ParaIncomplete
Average Risk
Morbidity risk ratio(age-adjusted)
HDL (mg/dl)
20 40 60 80
0
1.0
2.0
HDL-Cholesterol & CHD Risk(Men in Framingham, MA)
HD
L C
ho
lest
ero
l (m
g/d
L)
![Page 32: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/32.jpg)
HDL Cholesterol by Ethnicity
Bauman et al., Arch Phys Med Rehabil. 79:176-180, 1998.
![Page 33: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/33.jpg)
National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation and TreatmentOf High Blood Cholesterol in Adults
» 1988 Adult Treatment Panel (ATP) I» 1993 ATP II» 2001 ATP III
Guidelines for Assessment of Risk for CHD
2004 Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Over the years, the “target values” for LDL cholesterolhave become more conservative.
![Page 34: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/34.jpg)
Subjects: 41 subjects with paraplegia
• ASIA A & B: T6 to L1• Age: 34±11 years
Nash MS, et al. A guideline driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia. Arch Phys Med Rehabil. 88:751-757, 2007
Main Outcome Measure: % of subjects qualifying for intervention • Based on ATP III guidelines
![Page 35: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/35.jpg)
Results: 63% of subjects qualified for intervention » 76% had HDL cholesterol <40 mg/dL » ~1/3 had hypertension » 34% had the metabolic syndrome
Nash et al. Arch Phys Med Rehabil. 88:751-757, 2007.
Conclusion: A high percentage of young, healthy persons with SCI are at risk for CVD & qualify for lipid-lowering intervention.
Nash MS, et al. Arch Phys Med Rehabil. 88:751-757, 2007
![Page 36: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/36.jpg)
Risk Assessment for Coronary Heart Disease in a Veteran Population with Spinal Cord Injury. Topics in Spinal Cord Injury Rehabilitation. 12:35-53, 2007.
Purpose: » To determine the conventional risk factors for CHD & calculate risk for CHD to determine the target level for serum LDL cholesterol.
Population: » 224 outpatients with SCI associated with the VA Medical Center, Bronx, NY
Method: » Conventional risk factors for CHD were defined by the ATP III guidelines.
![Page 37: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/37.jpg)
Characteristics of the Study Group
Bauman et al., Topics in Spinal Cord Inj Rehabil. 12:35-53, 2007.
![Page 38: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/38.jpg)
Table 2
Major Risk Factors for CHD
Tetra (n=103) Para (n=119)
Bauman et al. Topics in Spinal Cord Inj Rehabil. 12:35-53, 2007.
![Page 39: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/39.jpg)
Table 3
Ten-Year Risk Assessment
Bauman et al. Topics in Spinal Cord Inj Rehabil. 12:35-53, 2007.
![Page 40: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/40.jpg)
Major Risk Factors for CHD
• Cigarette Smoking
• Hypertension (>140/90 mm Hg or on anti-hypertensive medications
• Low HDL cholesterol (<40 mg/dL)
• Family history of premature CHD (male first degree relative < 55 years; female first-degree relative < 65 years)
• Age (men > 45 years; women > 55 years
![Page 41: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/41.jpg)
Serum HDL Cholesterol Levels in the ATP III Stratification of Risk for CHD
HDL cholesterol has a dual function:
(1) Counted as a Major Risk Factor that serves to modify LDL goals
(2) Used to estimate the 10-year risk for developing CHD (using the Framingham
risk scoring system)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486-2497.
![Page 42: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/42.jpg)
Nash MS, et al. Extended-Release Niacin for Treatment of Dylipidemia in Chronic Tetraplegia
Subjects: 54 persons with chronic tetraplegia and low HDL cholestrol
Results: ↑ HDL (24.5%)
↓ LDL
↓ TC
↓ TC:HDL
↓ LDL:HDL
Conclusion: Extended-release niacin is safe, tolerated, and effective for most persons with chronic tetraplegia.
Unpublished observation.Supported by NIDRR, Department of Education
HDL LDL TC-20
-10
0
10
20
30
2000 mg
500 mg
1000 mg
1500 mg
Per
cent
Cha
nge
![Page 43: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/43.jpg)
● High-sensitivity CRP● Interleukin-6● Fibrinogen● Tumor Necrosis Factor-α● Increased concentration of small, dense LDL particles● Lp(a)● Homocysteine● Apolipoprotein A1 and B● Postprandial lipemia● Vitamin D
● Visceral fat
Emerging Risk Factors For Coronary Heart Disease
![Page 44: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/44.jpg)
Lee MY, et al. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury. J Spinal Cord Injury. 28:20-25, 2004.
C-reactive protein levels and IR C-reactive protein levels and Dyslipidemia
![Page 45: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/45.jpg)
Mortality Ratios for Plasma Homocysteine Levels for Men and Women with SCI
Bauman et al. J Spinal Cord Med. 24:81-86, 2001.
![Page 46: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/46.jpg)
Orakzai SH, et al. Measurement of coronary arterycalcification by electron beam computerized tomographyin persons with chronic spinal cord injury: evidencefor increased atherosclerotic burden. Spinal Cord. 2007
Subjects:
» 91 persons (76 men & 15 women) with chronic SCI matched 3:1 for age, gender, ethnicity & risk factors for CHD
Conclusions:
» Patients with SCI have greater atherosclerotic burden than able-bodied controls. This finding is beyond that explained by the traditional risk factors for CHD.
Results:
» The mean calcium score of the SCI group was significantly greater than the control group (75±218 versus 28±104, P<0.001)
» The prevalence of any CAC score was greater in the SCI population than the control population (51 versus 39%, P<0.05).
![Page 47: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/47.jpg)
● What factors best predict risk for CHD?
Questions to be Addressed
● Are the guidelines for treatment decisions to reduce risk for CHD transferable from the able-bodied population to persons with SCI?
Are there studies that have stratified persons with SCIfor risk of CHD on evidenced-based guidelines?
Is there a study that has determined CHD in personswith SCI compared with matched, able-bodied controls?
● Are persons with SCI at increased risk for CHD?
These questions have not been answered.
![Page 48: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/48.jpg)
Pulmonary Program
PI: Gregory J. Schilero MD
Study of the pathophysiology of spinal cord injury & the lung
Intervention(s) to increase expiratory muscle strength
Markers of lung inflammationInhibition of lung nitric oxide & effects on airway tone
![Page 49: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/49.jpg)
Fitted Values for FVC Percent Predicted by Vertebral Level for Complete Motor Lesions
4249
5560 64 67 70 73 76 79 81 83 86 88 89 91 93 94 96 97 99 100
0
20
40
60
80
100
120
C3 C4 C5 C6 C7 C8 T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 L1 L2 L3 L4
Pe
rce
nt
Pre
dic
ted
FV
C Normal Range
Lin & Spungen et al., Spinal Cord. 2001; 39:263-268.
![Page 50: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/50.jpg)
LUNG VOLUMES
ICTVERVRV
Normal Tetraplegia
FRC
FVC
Restrictive Findings Slight TLC FVC ERV RV
- Correlates with level of injury
![Page 51: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/51.jpg)
Pulmonary: Obstructive Disease in Individuals with Tetraplegia
Bronchodilators “unmask” obstruction
Increased airway tone
Hyperreactive airways to standard provocative testing
![Page 52: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/52.jpg)
Effects of Nitric Oxide Synthase Inhibition on Levels of Exhaled NO and Airway Tone in Subjects with Chronic Cervical SCI
• Measurement of exhaled levels of nitric oxide offers a non-invasive methodology to indirectly assess the degree of airway inflammation.
![Page 53: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/53.jpg)
Background● Asthma and spinal cord injury have similar findings of
reversible obstructive airway disease.
● In asthma, airway inflammation is present.
● The presence and/or role of airway inflammation in individuals with tetraplegia has not been reported.
● Airway inflammation may be a consequence of: (1) a systemic inflammatory response after acute SCI; (2) chronic underlying systemic inflammation; and/or (3) repetitive pulmonary infections 2º to ineffective cough.
![Page 54: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/54.jpg)
Baseline Values of Exhaled Nitric Oxide (NO)
*P= 0.0109#P= 0.0045
![Page 55: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/55.jpg)
8-Isoprostane Levels in Exhaled Breath Condensate (EBC)
8-isoprostane levels in tetraplegia (n=6), asthma (n=6) and control group (n=6). †p <0.05 vs. control group; *p <0.02 vs. control group
8-Isoprostane Levels
● 8-isoprostane levels represent pathways of inflammation seen in models of inflammation (e.g., COPD and asthma).
● 8-isoprostane is a marker of oxidative stress.
● In the able-bodied population, there is good correlation of 8-isoprostane with small airway function and small airway inflammation.
*
![Page 56: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/56.jpg)
Cardiovascular/Autonomic Program
PI: Jill M. Wecht, EdD
Chronic SCI• 24-hour monitoring of
hemodynamic parameters
• Interventions to reduce orthostatic hypotension
![Page 57: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/57.jpg)
24-hour Heart Rate
65
70
75
80
85
90
95
100
105
24-h
ou
r H
eart
Rat
e
8am noon 4pm 8pm midnight 4am 8am
P<0.001 versus AB & tetraplegic groups
controlsparaplegictetraplegic
Wecht et al., Unpublished observation.
![Page 58: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/58.jpg)
24 hour Systolic Blood Pressure
p<0.05 versus controls
tetraplegicparaplegicControl
95
100
105
110
115
120
125
130
135
24 H
ou
r S
BP
(m
mH
g)
8am noon 4pm 8pm midnight 4am 8am
Wecht et al., Unpublished observation.
![Page 59: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/59.jpg)
Efficacy of Drug or Physical Maneuver on BP and Cerebral Perfusion
Interventions
•α1-agonist (midodrine)
•nocturnal head-up tilt
•nitric oxide synthase inhibitor
![Page 60: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/60.jpg)
Sympathetic Cardiac Control
Grimm et al. Am J Physiol. 1997.
LF-RRI 0.04-0.15 Hz
0
1000
2000
3000
4000
5000
6000
7000
Control Para Tetra-Inc Tetra-Com
SUPINE
HUT
COLD PRESSOR
ISOMETRIC
Ab
solu
te L
F-R
RI (
mse
c2 /H
z)
![Page 61: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/61.jpg)
Parasympathetic Cardiac Control
0
1000
2000
3000
4000
5000
Control Para Tetra-Inc Tetra-Com
SUPINE
HUT
COLD PRESSOR
ISOMETRIC
Grimm et al., Am J Physiol. 1997.
HF-RRI 0.15-0.40 Hz
Ab
solu
te H
F-R
RI (
mse
c2 /H
z)
ISOMETRIC
![Page 62: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/62.jpg)
Sympathovagal Balance (LF/HF)
0
0.5
1
1.5
2
2.5
3
Control Para Tetra-Inc Tetra-Com
SUPINE
HUT
COLD PRESSOR
ISOMETRIC
Grimm et al., Am J Physiol. 1997.
Ab
solu
te L
F/H
F R
RI
(mse
c2 /H
z)
LF-RRI/HF-RRI
![Page 63: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/63.jpg)
Gastrointestinal Program
PI: Mark A. Korsten, MD
Assessment of drug therapy for treatment of difficulty with evacuation
Evaluation of elective colonoscopy
![Page 64: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/64.jpg)
Gastrointestinal MorbidityDifficulty with evacuation, especially
constipation and impaction, is common after SCI.
Bowel care requires regular use of laxatives, enemas and suppositories.
Bowel care is often time-consuming and labor intensive.
![Page 65: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/65.jpg)
Is there a practical pharmacological approach to bowel care on our clinical horizon?
![Page 66: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/66.jpg)
Placebo Neostigmine Neo+Glyco0
25
50
75
100
Complete
Most
Moderate
Some
None
Evacuation Rating
Per
cen
t o
f S
ub
ject
s
* *
*P < 0.01 compared to normal saline
Korsten et al., Amer J Gastroenterol. 2005.
Neostigmine and Glycopyrrolate on Bowel Evacuation in Persons with SCI
![Page 67: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/67.jpg)
» To study the quality of bowel preparation for colonoscopy after oral cleansers, bowel prokinetic agents, mechanical lavage, or a combination.
» To compare polyp detection rates in persons with SCI and able-bodied controls.
Elective Colonoscopy in Persons with SCI
![Page 68: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/68.jpg)
POLYP DETECTION RATE DURING COLONOSCOPY: ABLE- BODIED CONTROLS vs. SCI PATIENTS
Able bodied pa-tients (n=31)
SCI patients (n=32)
0
10
20
30
40
50
60 51.6
21.9
% c
olo
no
sco
pie
s w
ith
p
oly
ps
P = 0.02 by Fisher’s exact test
![Page 69: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/69.jpg)
Molecular ProgramPI: Christopher P. Cardozo, MD
Transcriptional regulation of anabolic/ catabolic factors in muscle
Effect of anabolic/ catabolic agents on muscle after denervation or SCI
Effect of anabolic agents on functional recovery
![Page 70: RR&D Center of Excellence for the Medical Consequences of Spinal Cord Injury William A. Bauman, M.D. Director Ann M. Spungen, Ed.D Co-Director January](https://reader037.vdocument.in/reader037/viewer/2022110401/56649e005503460f94ae9dee/html5/thumbnails/70.jpg)